TP53 and chronic myelogenous leukemia, BCR-ABL1 positive: while the KEGG enrichment analysis results contain “Chronic myeloid leukemia”, “Bladder cancer”, “PI3K−Akt signaling pathway”, “Pathways in cancer”, “MAPK signaling pathway”, “Proteoglycans in cancer”, “Cell cycle”, “p53 signaling pathway”.